Searchable abstracts of presentations at key conferences in endocrinology

ea0044ep96 | (1) | SFEBES2016

Acute confusion in a cyclist

Giannopoulou Angeliki , Hancock Sian , Kumar Senthil , Mallipedhi Akhila , Rice Sam

A 46-year-old male was brought to the hospital by his uncle as he was found to be acutely confused and agitated ‘talking rubbish’ and giggling inappropriately. Last time he was seen well was 3 days ago. He was a cyclist who lived alone and his past medical history included Graves’ disease and AF. He was on propranolol, carbimazole and warfarin. A month ago he needed admission to a different hospital after falling off his bike. At that time he also developed conf...

ea0015p121 | Diabetes, metabolism and cardiovascular | SFEBES2008

Cardiometabolic disease in adrenal insufficiency: is the risk increased?

Rice Sam , Agarwal Neera , Bolusani Hemanth , Rees Aled

Background and aims: Subjects with primary (PAI) and secondary adrenal insufficiency (SAI)/hypopituitarism have an increased cardiovascular mortality for reasons that are unclear. Arterial stiffness is an independent risk factor for increased cardiovascular mortality. We sought to measure arterial stiffness in subjects with AI and aimed to identify which factors might account for any increase observed.Methods: Ethical approval was obtained for this study...

ea0013p155 | Diabetes, metabolism and cardiovascular | SFEBES2007

Sodium valproate monotherapy increases ovarian hyperandrogenism but does not affect arterial compliance in young women with epilepsy

Rice Sam , Agarwal Neera , Bolusani Hemanth , Scanlon Maurice , Pierri Melissa , Smith Phil , Rees Aled

Background: Women with epilepsy may be at risk of developing PCOS, but it is unclear whether this is due to the disease or sodium valproate (VPA) therapy. We sought to determine androgenic status and cardiometabolic risk in women taking VPA monotherapy and compared these with subjects taking lamotrigine and healthy controls.Methods: Patients with epilepsy (age 18–43) with no known vascular risk were divided into 3 groups: VPA monotherapy (n=1...

ea0056p992 | Clinical case reports - Thyroid/Others | ECE2018

Significant cardiac disease complicating Graves’ disease in the young

Witczak Justyna , Ravindran Ravikumar , Rice Sam , Yousef Zahir , Premawardhana Lakdasa DKE

Introduction: Graves’ disease (GD) is associated with cardiac complications like tachydysrythmias, coronary ischaemia and cardiomyopathy. They are uncommon in the young. We present three individuals without previous cardiac disease, who developed significant cardiac complications of GD.Case presentations Subject 1: A 34-year-old female smoker, presented with breathlessness, palpitations, tremors and agitation for several weeks. Her fT4 was ...